Cargando…

Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients

Background: Microbiological diagnosis of aspergillosis and triazole resistance is limited by poor culture yield. To better estimate this shortcoming, we compared culture and molecular detection of A. fumigatus in respiratory samples from French patients at risk for aspergillosis. Methods: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yanan, Garnaud, Cécile, Brenier-Pinchart, Marie-Pierre, Thiébaut-Bertrand, Anne, Saint-Raymond, Christel, Camara, Boubou, Hamidfar, Rebecca, Cognet, Odile, Maubon, Danièle, Cornet, Muriel, Perlin, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965478/
https://www.ncbi.nlm.nih.gov/pubmed/27524978
http://dx.doi.org/10.3389/fmicb.2016.01164
_version_ 1782445261234110464
author Zhao, Yanan
Garnaud, Cécile
Brenier-Pinchart, Marie-Pierre
Thiébaut-Bertrand, Anne
Saint-Raymond, Christel
Camara, Boubou
Hamidfar, Rebecca
Cognet, Odile
Maubon, Danièle
Cornet, Muriel
Perlin, David S.
author_facet Zhao, Yanan
Garnaud, Cécile
Brenier-Pinchart, Marie-Pierre
Thiébaut-Bertrand, Anne
Saint-Raymond, Christel
Camara, Boubou
Hamidfar, Rebecca
Cognet, Odile
Maubon, Danièle
Cornet, Muriel
Perlin, David S.
author_sort Zhao, Yanan
collection PubMed
description Background: Microbiological diagnosis of aspergillosis and triazole resistance is limited by poor culture yield. To better estimate this shortcoming, we compared culture and molecular detection of A. fumigatus in respiratory samples from French patients at risk for aspergillosis. Methods: A total of 97 respiratory samples including bronchoalveolar lavages (BAL), bronchial aspirates (BA), tracheal aspirates, sputa, pleural fluids, and lung biopsy were collected from 33 patients having invasive aspergillosis (n = 12), chronic pulmonary aspergillosis (n = 3), allergic bronchopulmonary aspergillosis (n = 7), or colonization (n = 11) and 28 controls. Each specimen was evaluated by culture, pan-Aspergillus qPCR, and CYP51A PCR and sequencing. Results: One A. flavus and 19 A. fumigatus with one multiazole resistant strain (5.3%) were cultured from 20 samples. Culture positivity was 62.5, 75, 42.9, and 15.8% in ABPA, CPA, IA, and colonized patients, respectively. Aspergillus detection rate was significantly higher by pan-Aspergillus qPCR than by culture in IA (90.5 vs. 42.9%; P < 0.05) and colonization group (73.7 vs. 15.8%; P < 0.05). The CYP51A PCR found one TR(34)/L98H along with 5 novel cyp51A mutations (4 non-synonymous and 1 promoter mutations), yet no association can be established currently between these novel mutations and azole resistance. The analysis of 11 matched pairs of BA and BAL samples found that 9/11 BA carried greater fungal load than BAL and CYP51A detection was more sensitive in BA than in BAL. Conclusion: Direct molecular detection of Aspergillus spp. and azole resistance markers are useful adjunct tools for comprehensive aspergillosis diagnosis. The observed superior diagnostic value of BAs to BAL fluids warrants more in-depth study.
format Online
Article
Text
id pubmed-4965478
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49654782016-08-12 Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients Zhao, Yanan Garnaud, Cécile Brenier-Pinchart, Marie-Pierre Thiébaut-Bertrand, Anne Saint-Raymond, Christel Camara, Boubou Hamidfar, Rebecca Cognet, Odile Maubon, Danièle Cornet, Muriel Perlin, David S. Front Microbiol Microbiology Background: Microbiological diagnosis of aspergillosis and triazole resistance is limited by poor culture yield. To better estimate this shortcoming, we compared culture and molecular detection of A. fumigatus in respiratory samples from French patients at risk for aspergillosis. Methods: A total of 97 respiratory samples including bronchoalveolar lavages (BAL), bronchial aspirates (BA), tracheal aspirates, sputa, pleural fluids, and lung biopsy were collected from 33 patients having invasive aspergillosis (n = 12), chronic pulmonary aspergillosis (n = 3), allergic bronchopulmonary aspergillosis (n = 7), or colonization (n = 11) and 28 controls. Each specimen was evaluated by culture, pan-Aspergillus qPCR, and CYP51A PCR and sequencing. Results: One A. flavus and 19 A. fumigatus with one multiazole resistant strain (5.3%) were cultured from 20 samples. Culture positivity was 62.5, 75, 42.9, and 15.8% in ABPA, CPA, IA, and colonized patients, respectively. Aspergillus detection rate was significantly higher by pan-Aspergillus qPCR than by culture in IA (90.5 vs. 42.9%; P < 0.05) and colonization group (73.7 vs. 15.8%; P < 0.05). The CYP51A PCR found one TR(34)/L98H along with 5 novel cyp51A mutations (4 non-synonymous and 1 promoter mutations), yet no association can be established currently between these novel mutations and azole resistance. The analysis of 11 matched pairs of BA and BAL samples found that 9/11 BA carried greater fungal load than BAL and CYP51A detection was more sensitive in BA than in BAL. Conclusion: Direct molecular detection of Aspergillus spp. and azole resistance markers are useful adjunct tools for comprehensive aspergillosis diagnosis. The observed superior diagnostic value of BAs to BAL fluids warrants more in-depth study. Frontiers Media S.A. 2016-07-29 /pmc/articles/PMC4965478/ /pubmed/27524978 http://dx.doi.org/10.3389/fmicb.2016.01164 Text en Copyright © 2016 Zhao, Garnaud, Brenier-Pinchart, Thiébaut-Bertrand, Saint-Raymond, Camara, Hamidfar, Cognet, Maubon, Cornet, Perlin and the Grenoble Aspergillus Committee. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Zhao, Yanan
Garnaud, Cécile
Brenier-Pinchart, Marie-Pierre
Thiébaut-Bertrand, Anne
Saint-Raymond, Christel
Camara, Boubou
Hamidfar, Rebecca
Cognet, Odile
Maubon, Danièle
Cornet, Muriel
Perlin, David S.
Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients
title Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients
title_full Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients
title_fullStr Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients
title_full_unstemmed Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients
title_short Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients
title_sort direct molecular diagnosis of aspergillosis and cyp51a profiling from respiratory samples of french patients
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965478/
https://www.ncbi.nlm.nih.gov/pubmed/27524978
http://dx.doi.org/10.3389/fmicb.2016.01164
work_keys_str_mv AT zhaoyanan directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT garnaudcecile directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT brenierpinchartmariepierre directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT thiebautbertrandanne directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT saintraymondchristel directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT camaraboubou directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT hamidfarrebecca directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT cognetodile directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT maubondaniele directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT cornetmuriel directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients
AT perlindavids directmoleculardiagnosisofaspergillosisandcyp51aprofilingfromrespiratorysamplesoffrenchpatients